Compare Caprihans India with Similar Stocks
Dashboard
Weak Long Term Fundamental Strength with an average Return on Capital Employed (ROCE) of 0%
- Poor long term growth as Operating profit has grown by an annual rate -177.85% of over the last 5 years
- Low ability to service debt as the company has a high Debt to EBITDA ratio of 16.28 times
Risky - Negative Operating Profits
Consistent Underperformance against the benchmark over the last 3 years
Stock DNA
Plastic Products - Industrial
INR 141 Cr (Micro Cap)
NA (Loss Making)
35
0.00%
1.59
-11.23%
0.34
Total Returns (Price + Dividend) 
Latest dividend: 0.7 per share ex-dividend date: Sep-12-2019
Risk Adjusted Returns v/s 
Returns Beta
News

Caprihans India Ltd is Rated Strong Sell
Caprihans India Ltd is rated 'Strong Sell' by MarketsMOJO, with this rating last updated on 12 Feb 2025. However, the analysis and financial metrics presented here reflect the stock's current position as of 01 June 2026, providing investors with an up-to-date view of the company's performance and outlook.
Read full news articleAre Caprihans India Ltd latest results good or bad?
Caprihans India Ltd's latest financial results for Q4 FY26 reveal a complex picture of operational performance and persistent challenges. The company reported a net profit of ₹7.04 crores, a significant turnaround from a loss of ₹15.60 crores in the previous quarter, driven in part by exceptional other income amounting to ₹18.41 crores. This other income represented a substantial portion of the profit before tax, raising questions about the sustainability of the profitability achieved in this quarter. In terms of sales, the company experienced a sequential increase in net sales of 4.43%, reaching ₹183.07 crores, although this figure reflects a slight decline of 1.79% year-on-year. The operating margin improved to 9.96%, marking the highest level in eight quarters, indicating some operational efficiency gains. However, the underlying operating profit, excluding other income, remained negative, highlighting ...
Read full news article
Caprihans India Q4 FY26: Brief Profit Respite Masks Persistent Structural Weakness
Caprihans India Ltd., a micro-cap manufacturer of PVC films and pharma packaging materials, reported a net profit of ₹7.04 crores for Q4 FY26, marking a dramatic reversal from the ₹15.60-crore loss in Q3 FY26. However, this quarterly respite offers little comfort to investors grappling with the company's chronic profitability challenges, mounting debt burden, and deteriorating competitive position. With a market capitalisation of ₹121.00 crores, the stock closed at ₹74.00 on May 26, 2026, up 7.06% on the day, yet remains down 45.19% over the past year—a stark underperformance against the broader market and its sector peers.
Read full news article Announcements 
Intimation Of Lapse & Forfeiture Of Warrants
05-Jun-2026 | Source : BSECaprihans India Limited has informed the Exchange under Regulation 30 of SEBI (LODR) Regulations 2015 intimation of lapse and forfeiture of warrants
Disclosure Pursuant To Regulation 7(2)(B) Of SEBI (Prohibition Of Insider Trading) Regulations 2015
05-Jun-2026 | Source : BSECaprihans India Limited has submitted the disclosure under Regulation 7 of SEBI (PIT) Regulations 2015
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011
05-Jun-2026 | Source : BSEThe Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Bilcare Ltd
Corporate Actions 
No Upcoming Board Meetings
Caprihans India Ltd has declared 7% dividend, ex-date: 12 Sep 19
No Splits history available
No Bonus history available
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Mar 2026
Shareholding Compare (%holding) 
Promoters
None
Held by 1 Schemes (0.01%)
Held by 0 FIIs
Bilcare Limited (55.99%)
Rajesh Omkarnath Malpani (3.31%)
37.64%
Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ
QoQ Growth in quarter ended Mar 2026 is 4.43% vs 0.31% in Dec 2025
QoQ Growth in quarter ended Mar 2026 is 145.13% vs 37.32% in Dec 2025
Half Yearly Results Snapshot (Standalone) - Sep'25
Growth in half year ended Sep 2025 is -5.22% vs 6.26% in Sep 2024
Growth in half year ended Sep 2025 is 16.18% vs -129.05% in Sep 2024
Nine Monthly Results Snapshot (Standalone) - Dec'25
YoY Growth in nine months ended Dec 2025 is -6.58% vs 9.53% in Dec 2024
YoY Growth in nine months ended Dec 2025 is 15.49% vs -91.28% in Dec 2024
Annual Results Snapshot (Consolidated) - Mar'26
YoY Growth in year ended Mar 2026 is -4.85% vs 6.72% in Mar 2025
YoY Growth in year ended Mar 2026 is 25.00% vs -21.41% in Mar 2025






